PHARMEDIC
Board
2 directors, no change since 2023Director
appointed by deed of 08-03-2023
term without a fixed end
earlier manager, until 08-03-2023
Director
appointed by deed of 08-03-2023
term without a fixed end
earlier manager, until 08-03-2023
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Article 12. Pouvoirs de l’organe d’administration S’il n’y a qu’un seul administrateur, la totalité des pouvoirs d’administration lui est…”deed of 08-03-2023
Mandates through the years
4 names, the dashed line is todayDamienne HALLEUX
Director (not named in the articles)
Director (not named in the articles)
Jean-François JADIN
Director (not named in the articles)
Director (not named in the articles)
HALLEUX Damienne Anne Emmanuelle Ghislaine
Manager (not named in the articles)
Manager (not named in the articles)
JADIN Jean-François Henri Marie-Rose
Manager (not named in the articles)
Manager (not named in the articles)
BoardEarliermandate already running before its first mentionend not dated
Mandates as a list
- Damienne HALLEUX
- Director (not named in the articles), appointed by deed of 08-03-2023, still in office
- Manager, until 08-03-2023
- Jean-François JADIN
- Director (not named in the articles), appointed by deed of 08-03-2023, still in office
- Manager, until 08-03-2023
- HALLEUX Damienne Anne Emmanuelle Ghislaine
- Manager (not named in the articles), appointed by deed of 13-12-2018, last mentioned in 2018
- JADIN Jean-François Henri Marie-Rose
- Manager (not named in the articles), appointed by deed of 13-12-2018, last mentioned in 2018
Control
This company
PHARMEDIC
Equity €129,921
Profit €54,336 in 2025
Capital
- Contribution
- €18,600
- Shares
- 100
- Contribution per share
- €186
- Equity per share
- €1,299 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 08-03-2023 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Moitié cédant moitié acquéreurs au prorata si plusieurs, commun accord sinon président du tribunal de l'entreprise statuant comme en référé…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Monday of June
Shareholders
At incorporation
deed of 13-12-2018 ↗
- JADIN Jean-François Henri Marie-Rose 50 shares (50%) · €9,300
- HALLEUX Damienne Anne Emmanuelle Ghislaine 50 shares (50%) · €9,300
Capital transactions
Capital over time
- 08-03-2023 Converted to unavailable equity · €19,320
- 13-12-2018 Incorporation · €18,600 · 100 shares